A Phase I/II trial of fruquintinib in combination with paclitaxel for second-line treatment in patients with advanced gastric cancer

    Dongsheng Zhang
    Dongsheng Zhang
    Li Jin
    Li Jin
    Jing Huang
    Jing Huang
    Songhua Fan
    Songhua Fan
    Ke Li
    Ke Li
    Ye Hua
    Ye Hua

    Journal of Clinical Oncology, pp. 128-128, 2017.

    Cited by: 0|Bibtex|Views0|

    Abstract:

    128Background: Advanced gastric cancer (AGC) is a major problem particularly in Asian countries. The treatment options are limited after standard first line chemotherapy. This phase I/II study aimed to evaluate the tolerability, pharmacokinetics and preliminary efficacy of fruquintinib, a selective oral VEGFR inhibitor, combined with pacl...More

    Code:

    Data:

    Your rating :
    0

     

    Tags
    Comments